Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
PI is no longer at University of Rochester, has moved to University of Florida, Gainesville. PI email now homonq@ufl.edu. Phone is 352-273-7675
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to figure out some of the differences in bodily function between women who have preeclampsia and those who do not.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Controls | Gravidas without history of hypertension of any kind, and matched to cases for parity, gestational age, labor status, mode of delivery, maternal age, and race. |
| |
| Preeclamptics | Gravidas at 32-42 weeks gestation, delivered by Caesarean Section, who have preeclampsia as defined by Sibai et al, 1997. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| collection of maternal blood specimen prior to delivery | Procedure | approximately 5 cc. of maternal blood will be drawn prior to delivery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Relative pattern of expression in cases and matched controls of a robust set of genes in the VEGF/sFLT mediated model for preeclampsia in the placenta and decidua | 1- 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| From this expression pattern,determine the validity of 18s ribosomal subunit as an endogenous control in this tissue. | 1- 2 years | |
| Using relative expression analysis in an embedded set of control subjects, determine whether common variables e.g. labor, parity independently influence expression of these genes of interest in the tissues studied |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Gravidas at 32-42 weeks gestation who present to Labor and Delivery units at University of Rochester, Strong Memorial Hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eva Pressman, MD | University of Rochester | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Rochester Medical Center | Rochester | New York | 14642 | United States |
Not provided
Not provided
Not provided
Not provided
serum, placental and decidual tissue
| collection of placental cord blood after delivery | Procedure | approximately 5 cc. of fetal cord blood from the umbilical cord blood vessel will be collected after cord is clamped |
|
| collection of placental tissue | Procedure | within 10 minutes of delivery, the placenta will be radially transected, and a full-thickness slice from the central region removed using sterile technique by scalpel.This will be placed into a pre-prepared container of RNA preservation medium. |
|
| collection of strip of decidua from uterine lining from cesarean section deliveries | Procedure | A strip of decidua will be removed from the upper lip of uterine incision by the surgeon and placed in RNA preservation medium. |
|
| 1 - 2 years |
| Determine the population variance for each gene of interest | 1 - 2 years |
| ID | Term |
|---|---|
| D011225 | Pre-Eclampsia |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided